Uloric Box

About Uloric

Uloric (febuxostat) is a medication prescribed to lower uric acid levels in individuals with gout. Gout is a type of arthritis that occurs when a naturally occurring substance in the body known as uric acid builds up, causing sudden attacks of redness, swelling, and pain in joints. Approved for sale by the FDA in February 2009, Uloric is intended to lower uric acid levels in the bloodstream.

Invokana Amputations

Uloric Injury Risks

Upon initial FDA approval of Uloric, the FDA included a Warning and Precaution concerning cardiovascular events due to clinical trials conducted prior to the approval of the drug showing a higher rate of heart-related problems in patients treated with Uloric, as compared to alternative gout medication, allopurinol. These problems included heart attacks, strokes, and heart-related deaths.

As a result of these clinical trials, on February 21, 2019, the FDA required Takeda to update the Uloric labeling with a Black Box Warning about the increased risk of cardiovascular issues.

The FDA advises patients: Do not stop taking Uloric without first talking to your health care professional, as doing so can worsen your gout.

Case Evaluation

Case Evaluation »

We are currently accepting potential claims against the makers of Uloric by users who have been hospitalized for a cardiac event while taking Uloric. If you or a loved one has been injured due to use of Uloric, we would like to speak with you. Please send us your contact information and we will respond promptly.


Please fill in the form to request a FREE case evaluation from one of our attorneys if you or a loved one suffered from a cardiac event that required hospitalization while taking Uloric.

Have you or a loved one suffered from a cardiac event that required hospitalization while taking Uloric? *
 All personal information will be kept private. Please read our disclaimer.